Yuehong Wang

Shanghai Jiao Tong University — China

Medicine · Health Sciences

33h-index3.4kcitations126works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(14), Sulfur Compounds in Biology(11), Microtubule and mitosis dynamics(10), Cancer therapeutics and mechanisms(10), Natural product bioactivities and synthesis(8)

Publications126 total

Diabetic keratopathy and nuclear proteins (Review)
Molecular Medicine Reports·2025Open Access
Effects of combined auricular pressure bean and group guidance on sleep disorders in patients undergoing maintenance hemodialysis
Complementary Therapies in Clinical Practice·2025
Inside Back Cover: Deciphering the panvascular immune landscape of atherosclerosis (View 4/2025)
View·2025Open Access
Deciphering the panvascular immune landscape of atherosclerosis
View·2025Open Access
H2S inhibition of xanthine dehydrogenase to xanthine oxidase conversion reduces uric acid levels and improves myoblast functions
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research·2025· 3 cited
Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking TLR4‑NFκB‑driven ACE2 and TMPRSS2 pathways
Experimental and Therapeutic Medicine·2024· 6 citedOpen Access
Supplemental Figure 3 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Tables from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence
2023Open Access
Data from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Tables from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 1 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 3 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 2 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 4 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence
2023Open Access
Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence
2023Open Access
Data from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 4 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
Supplemental Figure 1 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Scott G. Franzblau(30), Hongzhu Li(11), Changqing Xu(10), Can Wei(10), Baojie Wan(9), Guido F. Pauli(8), Lingyun Wu(7), Barbara N. Timmermann(6), Alan P. Kozikowski(5), Shuzhi Bai(5), Rui Wang(5), Sang‐Hyun Cho(4), Weiming Sun(4), Hongxia Li(4), Meixiu Li(4), Hong-Jiang Shao(4), Taichi Inui(3), Zhenkun Ma(3), Birgit U. Jaki(3), Guangdong Yang(3)